UBS raises Medpace Holdings target price to $700 from $673
MEDP•UBS raised its target price for Medpace Holdings to $700 from $673.
Related News
Nasdaq trade halt continues; volatility trading pause at 9:31 a.m.
PASW•
LivaNova VNS Therapy shows 76% median seizure reduction at 36 months in study
LIVN•
Tompkins Financial raises quarterly dividend to $0.74 a share
TMP•
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
TEM•
US industrial new lease count index returns to record peak, CoStar says
CSGP•